Press Releases

Start of KIsSME Collaboration Project – Algorithms Capable of Learning Efficiently Capture Scenarios When Testing Highly Automated Vehicles

Massive Open Online Course (MOOC) for Better Self- and Time Management – Offer Open to All Interested Persons

KIT Retains Its Right to Accredit Its Study Programs

The Hessian state government is supporting cutting-edge research in Hesse with almost 40 million euros over a period of four years. Six projects of the universities in Darmstadt, Frankfurt, Giessen and Marburg together with further universities and non-university research institutions will be supported in the funding line "Cluster Projects" launched by the state from April 2021. In this way, the state is strengthening the research areas that shape the profile of Hessen's universities, including particle ph

On 19 February 2021, the 4000th eye tumour patient received irradiation with protons, performed by a joint team from Helmholtz-Zentrum Berlin (HZB) and Charité - Universitätsmedizin Berlin. The number of patients treated in 2020 remained at the previous year's level despite the more difficult corona conditions. The treatment in Berlin-Wannsee is only available for uveal melanomas of the eye. The proton accelerator at HZB is the only therapy site for this disease in Germany.

An international team has shown through a sensational experiment how diverse the possibilities for employing synchrotron light sources are. Accelerator experts from the Helmholtz-Zentrum Berlin (HZB), the German federal metrology institute Physikalisch-Technische Bundesanstalt (PTB), and Tsinghua University in Beijing have used a laser to manipulate electron bunches at PTB's Metrology Light Source so that they emitted intense light pulses having a laser-like character. Using this method, specialised synchrotron radiation sources would potentially be able to fill a gap in the arsenal of available light sources and offer a prototype for industrial applications. The work was published on 24 Fe...

Jülich, 24 February 2021 – The quantum computer race is in full swing. Germany has long been one of the world leaders in basic research. An alliance between Forschungszentrum Jülich and the semiconductor manufacturer Infinion, together with institutes of the Fraunhofer-Gesellschaft (IAF, IPMS) as well as the Leibniz Association (IHP, IKZ), the universities of Regensburg and Konstanz and the quantum startup HQS, now aims to apply the results to industrial production. The goal is a semiconductor quantum processor made in Germany that is based on the "shuttling" of electrons and is to be achieved with technology available in Germany. The QUASAR project, which is funded with over 7.5 million euros by the Federal Ministry of Education and Research (BMBF), aims to lay the foundations for the industrial production of quantum processors over the next four years.

Great honor for the HZG-Institute of Active Polymers

So-called silent mutations have no effect on the composition of a protein. They are therefore not considered to promote cancer. However, scientists from the German Consortium for Translational Cancer Research (DKTK), partner site Essen, now describe in a case of kidney cancer an overlooked silent mutation with a major impact on prognosis.In the DKTK, the German Cancer Research Center (DKFZ) in Heidelberg, as the core center, joins forces in the long term with university partner sites in Germany that have a special reputation in oncology.

New tool aims to make HCV vaccine search easier. Around 71 million people worldwide are infected with the hepatitis C virus (HCV). One reason why no vaccine against the virus has been found to date is that there are numerous virus variants, some of which differ by more than 30 percent from each other. Scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig, TWINCORE and the Hannover Medical School (MHH) have now succeeded ...